BLOOM SYNDROME
DNA ANALYSIS

Gene Mutation in the Ashkenazi Jewish Population
Bloom syndrome is an autosomal recessive disorder characterized clinically by a small size and typical facial appearance, and cytogenetically by an increased rate of chromosome breakage and sister chromatid exchange. The genomic instability in Bloom syndrome renders patients at a much higher risk for developing multiple types of cancers. This rare disease has a significantly higher incidence in the Ashkenazi Jewish population, wherein the carrier frequency was estimated at approximately 1 in 104. The Bloom syndrome gene BLM on chromosome 15q26.1 encodes a DNA helicase. While multiple BLM mutations have been identified, a specific mutation was found to be homozygous in Ashkenazi Jewish Bloom syndrome patients. This blmAsh mutation consists of a 6 base deletion and 7 base insertion at nucleotide 2281 of the BLM gene, which can be detected by a PCR-based diagnostic test. The Baylor DNA Diagnostic laboratory is offering diagnostic testing for the Bloom syndrome blmAsh mutation specific for the Ashkenazi Jewish population.

Reasons for Referral:

Diagnostic testing for Ashenazi Jewish individuals with a diagnosis or possible diagnosis of Bloom syndrome, or a positive family history of Bloom syndrome.

Testing Methodology:

PCR amplification of BLM gene sequences surrounding the blmAsh mutation at nucleotide 2281, and detection of the wild type and 2281del6ins7 mutation by allele-specific oligonucleotide (ASO) hybridization.

Sensitivity:

98% detection for Ashkenazi Jewish Bloom syndrome patients

Specimen Requirements:

Require 14 mls of blood in EDTA tube. Consent form must accompany specimen.

Turnaround Time:

3 weeks

CPT Codes and Prices:

83788, 83914, 83912, 83898, 83891

Shipping Information

Forms:

 >> DNA Requisition

Test Code:

6012